Section Arrow
Quote
WVE.NASDAQ
- Wave Life Sciences Ltd
Quotes are at least 15-min delayed:2026/02/21 21:56 EST
Regular Hours
Last
 13.49
+0.33 (+2.51%)
Day High 
13.5796 
Prev. Close
13.16 
1-M High
14.56 
Volume 
1.98M 
Bid
13.24
Ask
13.6
Day Low
12.88 
Open
13.07 
1-M Low
12.51 
Market Cap 
2.44B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 13.11 
20-SMA 13.2 
50-SMA 14.99 
52-W High 21.73 
52-W Low 5.28 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.65/-0.90
Enterprise Value
2.46B
Balance Sheet
Book Value Per Share
0.67
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
113.31M
Operating Revenue Per Share
0.20
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CDIOCardio Diagnostics Holdings Inc.2.88+0.64+28.57%-- 
IBRXImmunityBio8.7+0.09+1.05%-- 
GERNGeron Corp1.88-0.04-2.08%-- 
QNCXQuince Therapeutics0.1501-0.0121-7.46%-- 
RXRXRecursion Pharmaceuticals3.42-0.3-8.06%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform,PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsindeficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.